drugset / Trial / NCT00057239
An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
A Placebo Controlled Study Evaluating Efficacy, Safety and Tolerability of Radafaxine in Patients with Major Depressive Disorder (MDD)
Timeline
- Start
- 2003-03
- Primary completion
- 2004-05
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Radafaxine | Small molecule | 20 mg | Oral |
| Subject | Radafaxine | Small molecule | 60 mg | Oral |